FL118-14-Propanol(CAT: I040531) is a derivative of the potent anticancer agent FL118, structurally modified with a 1-propanol moiety to enhance solubility and pharmacokinetic properties. Like its parent compound, FL118-14-Propanol selectively inhibits key oncogenic proteins such as survivin, Mcl-1, XIAP, and cIAP2, contributing to its strong pro-apoptotic and antiproliferative effects in cancer cells. This compound shows promise in overcoming drug resistance and enhancing tumor selectivity, making it an attractive candidate for preclinical cancer research. FL118-14-Propanol is ideal for exploring structure–activity relationships and developing next-generation therapeutics targeting apoptosis pathways. Offered in high purity for oncology-focused biochemical and pharmacological investigations.